These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 22468915)

  • 1. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latest advances in molecular topology applications for drug discovery.
    Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
    Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR methods for the discovery of new inflammatory bowel disease drugs.
    García-Domenech R; Gálvez-Llompart M; Zanni R; Recio MC; Gálvez J
    Expert Opin Drug Discov; 2013 Aug; 8(8):933-49. PubMed ID: 23668227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the contribution of molecular topology to drug design and discovery.
    Gálvez J; García-Doménech R
    Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistamines.
    Galvez J; Galvez-Llompart M; Zanni R; Garcia-Domenech R
    Expert Opin Drug Discov; 2013 Mar; 8(3):305-17. PubMed ID: 23289365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
    Speck-Planche A; Cordeiro MN
    Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What place does molecular topology have in today's drug discovery?
    Zanni R; Galvez-Llompart M; Garcia-Domenech R; Galvez J
    Expert Opin Drug Discov; 2020 Oct; 15(10):1133-1144. PubMed ID: 32496823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
    Dobchev D; Karelson M
    Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries.
    Modi S; Hughes M; Garrow A; White A
    Drug Discov Today; 2012 Feb; 17(3-4):135-42. PubMed ID: 22063083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.
    Fang Y
    Expert Opin Drug Discov; 2015 Apr; 10(4):331-43. PubMed ID: 25727255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
    Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
    Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to molecular topology: basic concepts and application to drug design.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):196-223. PubMed ID: 22734705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of molecular topology for ulcerative colitis drug discovery.
    Bellera CL; Di Ianni ME; Talevi A
    Expert Opin Drug Discov; 2018 Jan; 13(1):89-101. PubMed ID: 29088918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.